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Posttranslational modifications of histone proteins play important roles in the modulation of gene expres-
sion. The Saccharomyces cerevisiae (yeast) 2-MDa SAGA (Spt-Ada-Gcn5) complex, a well-studied multisubunit
histone modifier, regulates gene expression through Gcn5-mediated histone acetylation and Ubp8-mediated
histone deubiquitination. Using a proteomics approach, we determined that the SAGA complex also deubiq-
uitinates nonhistone proteins, including Snf1, an AMP-activated kinase. Ubp8-mediated deubiquitination of
Snf1 affects the stability and phosphorylation state of Snf1, thereby affecting Snf1 kinase activity. Others have
reported that Gal83 is phosphorylated by Snf1, and we found that deletion of UBP8 causes decreased
phosphorylation of Gal83, which is consistent with the effects of Ubp8 loss on Snf1 kinase functions. Overall,
our data indicate that SAGA modulates the posttranslational modifications of Snf1 in order to fine-tune gene
expression levels.
Ubiquitination of cellular targets regulates many biological
processes, from intracellular trafficking to gene expression. Al-
though ubiquitination by ubiquitin (Ub) ligases is widely stud-
ied, less is known about subsequent deubiquitination (DUB) of
cellular substrates. The identification of genes coding 16 de-
ubiquitinases in the Saccharomyces cerevisiae (yeast) genome
and genes coding at least 60 deubiquitinases in the human
genome suggests that not only is deubiquitination important
but also that deubiquitination may also occur in a substrate-
specific manner to regulate specific cellular processes. Despite
the lack of knowledge of the targets of many of these deubiq-
uitinases, it is known that some of these enzymes impact cel-
lular growth and function (3, 21, 46). Overexpression of certain
deubiquitinases is associated with progression of malignancy in
neuroblastomas and a variety of carcinomas, indicating that
these enzymes may be oncogenic (27, 31, 38).
USP22, a deubiquitinase associated with the SAGA histone
acetyltransferase (HAT) complex, was identified as a member
of an 11-gene “death-from-cancer” signature that serves as a
predictor of treatment resistance, aggressive growth, and
metastasis of human tumors when overexpressed (7, 8). The
SAGA complex is highly conserved, and its functions are best
characterized in yeast (4, 9, 17, 23, 35). In addition to acety-
lating histone H3 via the Gcn5 subunit, SAGA also proteolyti-
cally cleaves ubiquitin moieties from histone H2B via the Ubp8
subunit, which is an ortholog of USP22 (13, 47). Ubp8-medi-
ated deubiquitination of histone H2B regulates the expression
of target genes by modulating the level of histone H3 lysine 4
methylation, a mark that is associated with active transcription
(13). In addition, Ubp8 facilitates the recruitment of the C-
terminal domain kinase (Ctk1) to target gene promoters via
histone H2B deubiquitination, which facilitates the transition
from transcription initiation to elongation (43).
Interestingly, recent studies indicate that the functions of
USP22 extend beyond histone H2B, as it also deubiquitinates
components of the shelterin complex, such as TRF1 (2). De-
ubiquitination of TRF1 regulates its stability, thereby affecting
telomere maintenance. The SAGA complex then may regulate
a wide variety of cellular processes that extend beyond altera-
tion of chromatin structures.
To address the possibility that additional factors may be
targets of Ubp8/USP22-mediated deubiquitination, we per-
formed a proteomic screen in Saccharomyces cerevisiae.
Here, we report that Ubp8 can deubiquitinate Snf1, a highly
conserved AMP-activated serine/threonine protein kinase
that serves as an energy sensor in the cell. Our data indicate
that hyperubiquitination of Snf1 affects its stability as well as its
phosphorylation status, which is known to affect Snf1 kinase
activity (14, 24, 36). Together, our results suggest that SAGA
functions as a master regulator of gene expression not only by
altering chromatin structures but also by regulating the stabil-
ity and activity of transcriptional modulators.
MATERIALS AND METHODS
Plasmids. Plasmid pUb221 (a generous gift of Daniel Finley [44]) contains a
6His-myc-ubiquitin construct under the control of the copper-inducible CUP1
promoter, TRP1 and URA3 selectable markers, and a 2m origin of replication.
Plasmid pESC-LEU (Stratagene) contains a LEU2 selectable marker, a 2m
origin of replication, and two multicloning sites downstream of the GAL1 and
GAL10 yeast promoter. Each multicloning site allows the addition of either a
myc or FLAG epitope-tagged gene of interest, respectively. Plasmid pMW10 is
a derivative of pESC-LEU and contains a myc-tagged UBP8 gene under the
control of the GAL1 promoter. Plasmid pMW18 is a derivative of pESC-LEU
and contains a FLAG-tagged SNF1 gene under the control of the GAL10 pro-
moter. Plasmid pMW22 is a derivative of pMW10 and contains a myc-tagged
UBP8 gene under the control of the GAL1 promoter and a FLAG-tagged SNF1
gene under the control of the GAL10 promoter. Plasmid pRG145 (a generous
gift of Richard Gardner), contains a three-hemagglutinin (3HA)-tagged ubiq-
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uitin construct under the control of the TDH3 promoter, a URA3 selectable
marker, and a 2m origin of replication.
Yeast transformations. Yeast strains were transformed as previously described
(Table 1) (6). To delete UBP8 or SNF1, we PCR amplified the disrupted gene
from a yeast deletion strain in the Open Biosystems collection (YSC1021-55154
or YSC1021-555840, respectively) by using primers that annealed 500 bp upstream
and downstream of the indicated open reading frame (UBP8 upstream primer
oMW3, AACTTTTCCATTTCGGCG; UBP8 downstream primer oMW4, GCC
AAAGACGGATATTCTTGG) (SNF1 upstream primer oMW136, AAAAGG
ATGGGCGTGATGAT; SNF1 downstream primer oMW137, GCAATGGGA
GCAAAATTTCC). A one-step gene replacement was performed in the
indicated strains by transformation using standard techniques (42). To confirm
the deletion of either UBP8 or SNF1, we PCR amplified G418-resistant colonies
with primers that annealed within the KANMX6 cassette (KANC, TGATTTT
GATGACGAGCGTAAT) and 700 bp downstream of the indicated open read-
ing frame (UBP8 downstream primer oMW140, CCGATGCAGAAAATGAAC
TCGGTG; SNF1 downstream primer oMW139, CTAACATCTTGTCCAAAT
GTTGG).
Detection of hyperubiquitinated Snf1 in the absence of UBP8. An analysis of
Snf1 ubiquitination was performed under denaturing conditions with isogenic
wild-type (YSC1178-750067) and ubp8 (yMW114) strains expressing a tandem
affinity purification (TAP)-tagged version of Snf1 (Snf1-TAP) and copper-induc-
ible 6His-myc-ubiquitin construct as previously described but with modifica-
tions (37). Briefly, overnight cultures grown in 5 ml of synthetic complete me-
dium minus uracil (SC-URA) plus 2% glucose were diluted in 50 ml of SC-URA
plus 2% glucose to a starting optical density at 600 nm (OD600) of 0.2 and grown
to an OD600 of 0.6 at 30°C. Twenty micromolar Z-Leu-Leu-Leu-al (MG132;
Sigma, St. Louis, MO) and 500 M CuSO4 were then added at final concen-
trations to each culture for 2 h, and cellular pellets were collected by cen-
trifugation. Samples were lysed in 1 ml of cold buffer A (6 M guanidine-HCl,
0.1 M Na2HPO4/NaH2PO4, 10 mM imidazole, pH to 8.0). Clarified extracts
were incubated with 50 l of preequilibrated nickel-nitrilotriacetic acid
(NTA) agarose beads (Qiagen, Valencia, CA) for 2 h and then washed 3 times
for 10 min with buffer A. Next, samples were washed 3 times for 10 min in
buffer A-buffer TI (1 volume of buffer A, 3 volumes of buffer TI [25 mM
Tris-HCl, 20 mM imidazole, pH to 6.8]) and then once with buffer TI and
boiled in 5 SDS-PAGE loading buffer containing 200 mM imidazole. Next,
eluates were separated by SDS-PAGE, transferred to nitrocellulose mem-
branes, and probed with anti-protein A antibodies (Molecular Probes, Eu-
gene, OR) to detect Snf1-TAP.
In order to detect hyperubiquitination of the Snf1-FLAG construct in the
absence of UBP8, 50-ml cultures of wild-type and ubp8 strains grown in syn-
thetic complete medium minus leucine and uracil (SC-Leu-URA) plus 2%
galactose and 2% sucrose in the presence of MG132 (see above) were lysed in
750 l of IP300 buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 2 mM MgCl2,
0.1% Triton X-100, 10% glycerol, 1 mM -mercaptoethanol [-ME], Complete
protease inhibitors [Roche, Indianapolis, IN]). Snf1-FLAG was then purified
from each lysate by using anti-FLAG agarose beads (Sigma, St. Louis, MO) in
the presence of a deubiquitination (DUB) inhibitor (10 mM N-ethylmaleimide
[NEM]) and MG132. Eluates were separated by SDS-PAGE and transferred to
nitrocellulose membranes which were then probed with either anti-FLAG anti-
bodies (Sigma, St. Louis, MO) or anti-myc antibodies (Santa Cruz Biotechnol-
ogies, Santa Cruz, CA) to detect Snf1-FLAG and the 6His-myc-Ub reporter,
respectively.
Coimmunoprecipitation of Ubp8 and Snf1. BY4741 strains containing plasmid
pESC-LEU, pMW10, pMW18, or pMW22 grown to a final OD600 of 0.8 in 50 ml
of SC-Leu plus 2% galactose and 2% sucrose were lysed in 750 l of IP300 buffer
(50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 2 mM MgCl2, 0.1% Triton X-100, 10%
glycerol, 1 mM -ME, Complete protease inhibitors [Roche, Indianapolis, IN]).
Lysates were then preincubated with 200 units of DNase I for 1 h followed by
a 3-h incubation with either 50 l of preequilibrated anti-FLAG or anti-myc
affinity resin (Sigma, St. Louis, MO) followed by three 10-min washes with 1
ml of IP300. Next, the beads were boiled in 5 SDS-PAGE loading buffer,
and the proteins within the supernatant were separated by SDS-PAGE,
transferred to nitrocellulose membranes, and probed with either anti-FLAG
(Sigma, St. Louis, MO) or anti-myc (Santa Cruz Biotechnologies, Santa Cruz,
CA) antibodies.
In order to determine if endogenous Snf1 and Ubp8 strains interact, YSC1178-
7502243, BY4741, and yMW100 strains were grown to a final OD600 of 0.8 in 50
ml of yeast extract-peptone (YEP) plus 2% glucose and were lysed in 1 ml of
IP300 buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 2 mM MgCl2, 0.1% Triton
X-100, 10% glycerol, 1 mM -ME, Complete protease inhibitors [Roche,
Indianapolis, IN]). Lysates were then preincubated with 200 units of DNase
I for 1 h followed by a 4-h incubation with 40 l of preequilibrated nickel-
NTA agarose beads (Qiagen, Valencia, California) followed by three 10
min-washes with 1 ml of IP300. Next, the beads were boiled in 5 SDS-PAGE
loading buffer, and the proteins within the supernatant were separated by
SDS-PAGE, transferred to nitrocellulose membranes, and probed with either
anti-6His (Qiagen, Valencia, CA) or anti-protein A (Molecular Probes,
Eugene, OR) antibodies.
Isolation of the SAGA complex. The SAGA complex was purified as previously
described with modifications (18). Briefly, overnight cultures of YSC1178-
7500046 and yMW122 were diluted into 12 liters of YEP plus 2% glucose to a
starting OD600 of 0.2 and grown to a final OD600 of 0.8, collected by centrifu-
gation, and resuspended in 150 ml of SAGA isolation buffer (40 mM HEPES, pH
7.4, 350 mM NaCl, 10% glycerol, 0.1% Tween 20 plus aprotinin [4 g/ml],
leupeptin [4 g/ml], pepstatin [2 g/ml], benzamidine [4 g/ml], and phenyl-
methylsulfonyl fluoride [PMSF; 200 g/ml]). Samples were lysed in a bead beater
(Biospec) containing 150 ml of cold acid-washed glass beads with five 1-min
beating cycles following by 5 min of cooling on ice. Clarified extracts were
incubated with 500 l of preequilibrated IgG sepharose (GE Healthcare,
Piscataway, NJ) overnight and then washed twice with 10 ml of SAGA
isolation buffer. Next, the beads were washed with 10 ml of TEV cleavage
buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% NP-40, 0.5 mM EDTA,
10% glycerol, 1 mM dithiothreitol [DTT] plus aprotinin [4 g/ml], leupeptin
[4 g/ml], pepstatin [2 g/ml], benzamidine [4 g/ml], and phenylmethylsul-
fonyl fluoride [200 g/ml]). The beads were then resuspended in 350 l of
TEV cleavage buffer containing 150 U of TEV protease (Invitrogen, Carls-
bad, CA) overnight at 4°C. Eluates were collected, flash frozen in liquid
nitrogen, and stored at 80°C.
In vitro DUB assay. Ubiquitinated H2B purified from yKL142 (kindly provided
by Jerry Workman) or ubiquitinated Snf1 purified from yMW16 containing
TABLE 1. Saccharomyces cerevisiae strains used in this study
Strain Genotype Source or reference
BY4741 MATa his31 leu20 ura30 met150 Open Biosystems
yMW16 MATa his31 leu20 ura30 met150 ubp8::KanMX6 This study
YSC1178-7500067 MATa his31 leu20 ura30 met150 SNF1-TAP::HIS3MX6 Open Biosystems
yKL142 MATa ura3-1 leu2-3,112 his3-11,15 trp1-1 ade2-1 htb1-1 htb2-1 pRS314 (FLAG-
HTB1-CEN-TRP1) ubp8::KanMX6 pRG145
(GAPDHp-3HA-UBI4-URA3 integrative)
18
YSC1178-7500046 MATa his31 leu20 ura30 met150 ADA2-TAP::HIS3MX6 Open Biosystems
yMW114 MATa his31 leu20 ura30 met150 SNF1-TAP::HIS3MX6 ubp8::KanMX6 This study
yMW122 MATa his31 leu20 ura30 met150 ADA2-TAP::HIS3MX6 ubp8::KanMX6 This study
YSC1178-7500191 MATa his31 leu20 ura30 met150 GAL83-TAP::HIS3MX6 Open Biosystems
YSC1021-555840 MATa his31 leu20 ura30 met150 snf1::KanMX6 Open Biosystems
yMW129 MATa his31 leu20 ura30 met150 GAL83-TAP::HIS3MX6 ubp8::KanMX6 This study
yMW134 MATa his31 leu20 ura30 met150 GAL83-TAP::HIS3MX6 snf1::KanMX6 This study
YSC1178-7502243 MATa his31 leu20 ura30 met150 UBP8-TAP::HIS3MX6 Open Biosystems
yMW100 MATa his31 leu20 ura30 met150 snf1::KanMX6 This study
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pRG145 was incubated in DUB buffer (50 mM Na-HEPES, pH 7.5, 0.5 mM
EDTA, 1 mM DTT, 0.1 M NaCl, 0.1 mg/ml ovalbumin) with SAGA complexes
that were isolated from either YSC1178-7500046 or yMW122 strains. The reac-
tion mixtures were incubated for 15 min at 30°C. SDS-PAGE loading buffer (5)
was added to each sample and boiled at 95°C for 5 min. Samples were separated
by SDS-PAGE, transferred to nitrocellulose membranes, and subjected to a
Western blot analysis with anti-FLAG antibodies (Sigma, St. Louis, MO),
anti-HA antibodies (Roche, Indianapolis, IN), and anti-H2B antibodies (Active
Motif, Carlsbad, CA). To ensure that equal amounts of SAGA containing and
lacking Ubp8 were used in each experiment, each blot was then probed with
anti-TAP antibodies (Open Biosystems, Huntsville, AL) to detect Ada2-CBP
levels (see Fig. 4B and D, bottom panels).
In vitro HAT assay. Recombinant histone H3 (NEB, Ipswich, MA) was incu-
bated for 1 h with SAGA complexes containing or lacking Ubp8 in histone
acetyltransferase (HAT) buffer (50 mM Tris-HCl, pH 8.0, 10% glycerol, 0.1 mM
EDTA, 1 mM DTT, 1 mM PMSF) containing [3H]acetyl coenzyme A ([3H]ace-
tyl-CoA) at 37°C. Following the incubation, 5 SDS-PAGE loading buffer was
added to each sample and samples were boiled at 95°C for 5 min. Samples were
separated by SDS-PAGE and stained with Coomassie blue. Next, the gel was
incubated with En3Hance (Perkin Elmer Life Sciences, Waltham, MA) for 1 h
and washed with distilled water for 30 min. The gel was then dried overnight in
a gel dryer on Whatman paper and exposed to autoradiograph film for 24 h to
detect [3H]acetyl-histone H3 levels.
Steady-state levels of SNF1mRNA. Overnight cultures of BY4741 and yMW16
strains were diluted in 5 ml of YEP plus 2% glucose to a starting OD600 of 0.2
and grown to a final OD600 of 0.8 at 30°C. Cell pellets were collected from each
sample and stored immediately on dry ice. Next, RNA was isolated from each
sample by standard phenol-chloroform extraction procedures. Purified RNA was
then subjected to either Northern blotting or quantitative reverse transcription-
PCR (RT-PCR) methods.
Stability of the Snf1-FLAG protein. Overnight cultures of BY4741 and
yMW16 strains containing pMW18 were diluted in 50 ml of SC-Leu plus 2%
galactose and 2% sucrose to a starting OD600 of 0.2 and grown to a final OD600
of 0.8. At this point, cell pellets were collected by centrifugation and resuspended
in 20 ml of SC-Leu without sugar. For time zero, a 1.5-ml aliquot was taken from
each sample, and following centrifugation, the remaining cell pellet was imme-
diately placed on dry ice. Next, transcription and translation were terminated by
the addition of 4% glucose and 100 g/ml of cycloheximide (Sigma, St. Louis,
MO) to the media. Aliquots of each sample were taken at the indicated time
points. Next, whole-cell extracts from each sample were analyzed by Western
blotting with anti-FLAG antibodies (Sigma, St. Louis, MO) and anti-Pgk1 anti-
bodies (Molecular Probes, Eugene, OR). Signals were quantified by using
ImageQuant software.
In order to determine if the observed proteolysis in ubp8 strains was due to
proteasome-mediated degradation of Snf1, the experiments were repeated as
described above, except that 20 M Z-Leu-Leu-Leu-al (MG132; Sigma, St.
Louis, MO) was added at each step, starting with the media 2 h before time zero.
Snf1 T210 phosphorylation measurements. Overnight cultures of YSC1178-
7500067 and yMW114 were diluted in 5 ml of the indicated media to a starting
OD600 of 0.2 and grown to a final OD600 of 0.8 at 30°C. Cell pellets were
collected by a 30-s centrifugation at 8,000  g and quickly placed in liquid
nitrogen. Cell extracts were then made by standard alkaline lysis and trichloro-
acetic acid (TCA) precipitation procedures with some modifications (26). Briefly,
2.7  107 cells were resuspended in 500 l of cold double-distilled water
(ddH2O). Eighty microliters of NaOH mix (1.85 M NaOH, 7.4% -ME) was
added to each tube, followed by incubation on ice for 10 min. Next, 80 l of 50%
TCA was added to each sample and incubated on ice for 10 min. Each sample
was centrifuged for 4 min at 3,300 g at 4°C. The supernatant was discarded and
cell pellets were washed with 500 l of 1 M Tris-HCl, pH 6.8. Sample pellets were
collected and resuspended in 150 l of 5 SDS-PAGE loading buffer. Samples
were then separated by SDS-PAGE, transferred to nitrocellulose membranes,
and probed with anti-protein A antibodies (Sigma, St. Louis, MO), anti-Pgk1
antibodies (Molecular Probes, Eugene, OR), or anti-phospho-Snf1 T210 anti-
bodies (Cell Signaling, Danvers, MA).
Gal83 phosphorylation measurements. Overnight cultures of YSC1178-
7500191, yMW129, and yMW134 grown in YEP plus 2% glucose were diluted in
100 ml of YEP plus 2% glucose to a starting OD600 of 0.2 and grown to a final
OD600 of 0.7 at 30°C. Cell pellets were collected from each sample and washed
in 50 ml of ddH2O and resuspended in 100 ml of YEP plus 2% glucose, YEP plus
2% galactose, or YEP plus 3% glycerol and 2% ethanol for 45 min. Cell pellets
were then collected and frozen in liquid nitrogen. Whole-cell lysates were col-
lected from each strain following resuspension of pellets in 1 ml of IP150 buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM MgCl2, 0.1% Triton X-100, 10%
glycerol, 2 Complete protease inhibitors [Roche, Indianapolis, IN], 2 Phos-
Stop phosphatase inhibitors [Roche, Indianapolis, IN]). Lysates were normalized
and incubated for 3 h with 20 l of preequilibrated IgG Sepharose (GE Health-
care, Piscataway, NJ) at 4°C and washed 3 times for 10 min each with IP150.
Next, the beads were boiled in 5 SDS-PAGE loading buffer and eluates were
separated by SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF)
membrane. Phospho-Gal83 was detected by staining the membrane with Pro-Q
Diamond stain (Invitrogen, Carlsbad, CA). Briefly, the membrane was allowed to
completely dry and then dipped in methanol. Next, the membrane was placed
into a fix solution (7% acetic acid, 10% methanol) for 10 min and then washed
4 times with ddH2O for 5 min. The membrane was stained for 15 min with Pro-Q
Diamond stain and destained with three 5-min washes in destain solution (50
mM sodium acetate [NaOAc], pH 4.0, 20% acetonitrile). The membrane was
then dried and phospho-Gal83 was visualized on a Storm840 scanner. Total
Gal83 was detected with an anti-protein A antibody (Sigma, St. Louis, MO) and
visualized by using the Storm840 scanner.
RESULTS
The ubiquitination status of Snf1 is altered in the absence of
Ubp8. To identify potential Ubp8 substrates, we isolated ubiq-
uitinated proteins from wild-type and ubp8 strains. Our rea-
soning was that ubiquitination of Ubp8 substrates would be
increased in its absence, leading to an increased abundance of
these proteins in ubiquitin isolations from ubp8 strains. The
details of the isolation and a full list of potential targets iden-
tified by this screen will be presented elsewhere, but mass
spectrometry of the isolated proteins identified Snf1 as a po-
tential target of Ubp8. Snf1 was identified in two independent
experiments, as was the known Ubp8 target, histone H2B (data
not shown).
Snf1 is the founding member of the SNF1 family of AMP
kinases (AMPKs), which is highly conserved from yeast to
mammals (5, 10, 30). While it is involved in a wide variety of
cellular processes, its major function in yeast is to induce ex-
pression of glucose-repressed genes when cells are grown on
nonfermentable carbon sources through phosphorylation-
mediated activation and deactivation of transcriptional regu-
lators (28). To confirm the results of our biochemical screen,
we purified 6His-myc-ubiquitin from wild-type and ubp8
strains expressing a tandem affinity purification (TAP)-tagged
version of Snf1 and a 6His-myc epitope-tagged ubiquitin
construct. After extensive washing, Ni-NTA-bound proteins
were resolved by SDS-PAGE and analyzed by Western blot
analyses with anti-TAP antibodies (Fig. 1A and B). We de-
tected some ubiquitination of Snf1 in wild-type strains, but the
abundance of the Snf1 ubiquitination was notably increased
upon loss of Ubp8, further indicating that Snf1 is a target of
Ubp8-mediated deubiquitination.
Hyperubiquitination of Snf1 triggers proteasome-mediated
degradation. Ubiquitination of a protein can trigger its prote-
olysis. The isolations described above were performed in the
presence of proteasome inhibitors in order to capture and
enrich samples for ubiquitinated Ubp8 targets. To determine
whether degradation of Snf1 is increased upon its hyperubiq-
uitination, we determined whether steady-state levels of Snf1
were decreased in ubp8 strains. Importantly, we found that
SNF1 mRNA levels were unchanged in wild-type and ubp8
strains (Fig. 1C). Western blots, however, revealed that Snf1
protein levels decreased in the absence of Ubp8 (Fig. 2A
and B).
To confirm that the decrease in Snf1 levels occurs posttrans-
lationally, we monitored the stability of Snf1 expressed under
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the control of a galactose-inducible promoter at various time
points following a shift of cells to repressing conditions (the
addition of glucose) in the presence of cycloheximide, thus
blocking transcription and translation of Snf1. Snf1 proteolysis
occurred rapidly in ubp8 strains relative to wild-type strains
(Fig. 2C and D). Further, this decrease in Snf1 stability was
dependent on the carbon source, as it was observed only for
ubp8 strains grown in galactose (Fig. 2E). Together, these
data suggest that Ubp8 regulates Snf1 levels posttranslationally
during growth on alternative carbon sources. In addition, the
MG132 proteasome inhibitor stabilized Snf1 in ubp8 strains
(ubp8 plus MG132; Fig. 2C and D), indicating that Ubp8-
mediated deubiquitination protects Snf1 from proteasome-me-
diated degradation.
Snf1 and Ubp8 are associated in vivo. The finding that the
ubiquitination status and stability of Snf1 are altered in ubp8
strains strongly suggests that Snf1 is a novel nonhistone sub-
strate of Ubp8. If Ubp8 deubiquitinates Snf1, then we would
expect to find interactions between these two proteins in vivo.
To test this hypothesis, we coexpressed a FLAG epitope-
tagged form of Snf1 and a myc epitope-tagged form of Ubp8
expressed from plasmid constructs. Western blots of anti-myc
or anti-FLAG immunoprecipitates were probed with anti-
FLAG or anti-myc antibodies to confirm that Snf1 and Ubp8
interact in vivo (Fig. 3A and B). In addition, we were still able
to detect these interactions in the presence of DNase and with
the endogenously tagged proteins, indicating that the interac-
tions are not mediated by DNA or are an artifact of the
overexpression of these proteins, further supporting our hy-
pothesis that Snf1 is a substrate of Ubp8 (Fig. 3A, B, and C).
Ubp8 can deubiquitinate Snf1 in vitro. To determine if Ubp8
can deubiquitinate Snf1 in vitro, we purified SAGA from
strains that expressed a TAP-tagged version of Ada2, a com-
ponent of the SAGA complex. In addition, we purified FLAG-
tagged Snf1 from a strain that also expressed HA-tagged ubiq-
uitin to be used as a substrate in these assays (Fig. 4C). For
controls, in addition to purifying the known Ubp8 target, his-
tone H2B, from a strain that also expressed HA-tagged ubiq-
uitin (Fig. 4A), we performed an in vitro DUB assay with
Ub-AMC (7-amino-4-methylcoumarin) to monitor the DUB
activity of the purified complexes (Fig. 4F). Ubiquitinated Snf1
or H2B was incubated in the absence and presence of the
SAGA complex and analyzed by use of anti-FLAG, anti-H2B,
and anti-HA Western blots to determine whether SAGA could
cleave ubiquitin from these proteins (Fig. 4B and D). SAGA
cleaved ubiquitin from both histone H2B (Fig. 4B, lane 2) and
Snf1 (Fig. 4D, lane 2). To confirm that the ability of SAGA to
deubiquitinate Snf1 was specific to the activity of Ubp8, we
also purified the SAGA complex from ubp8 strains. While the
in vitro histone acetyltransferase activity of SAGA remained
intact in the ubp8 strain (Fig. 4E, bottom panel, compare
lanes 3 and 4), we observed a complete loss of SAGA-medi-
ated deubiquitination of both histone H2B and Snf1, indicating
that the observed deubiquitination described above was medi-
ated by Ubp8 (Fig. 4B and D, lanes 3, and F). Together, these
data indicate that Ubp8 can directly deubiquitinate Snf1.
Snf1 hyperubiquitination corresponds to a decrease in Snf1
phosphorylation. The activity of Snf1 and related AMP kinases
is highly regulated (34). In mammals, AMPK acts as an energy
sensor that becomes activated when cellular ratios of AMP to
ATP are altered, which likely contributes to survival of a vari-
ety of tumors in nutrient-poor or hypoxic conditions. For ex-
ample, for human glioblastoma multiform tumors, microenvi-
ronments of hypoxia that alter the energy balance of AMP and
ATP result in increased expression of AMPK. Further, in
glioma cell lines, hyperactive AMPK causes an increase in the
expression of vascular endothelial growth factor (VEGF), a
factor necessary for angiogenesis and survival of these high-
grade tumors (25).
The activity of the Snf1 family is regulated in many different
ways. One highly conserved mechanism involves the phosphor-
ylation of the T loop at threonine 210 (T210) (14, 19, 24, 36),
which closely parallels the activation of Snf1 and many other
AMP kinases. When yeast cells grown in glucose are switched
to less-preferred carbon sources, Snf1 becomes phosphory-
lated and then activates the expression of genes involved in
utilization of these carbon sources by regulating the activity of
downstream transcriptional modulators (12, 20, 28, 29, 33, 39).
Interestingly, hyperubiquitination of mammalian Snf1-related
AMP-activated protein kinases is associated with a marked
decrease in T-loop phosphorylation, suggesting that ubiquiti-
nation regulates their activity (1).
To determine whether the hyperubiquitination of Snf1 that
we observed for ubp8 strains affects its phosphorylation sta-
tus, we monitored Snf1 T210 phosphorylation in wild-type and
FIG. 1. In the absence of Ubp8, Snf1 becomes hyperubiquitinated.
(A) Western blot analyses of Snf1 ubiquitination levels in the presence
and absence of Ubp8. A 6His pull-down of the 6His-myc-ubiquitin
reporter construct followed by an anti-PtnA Western blot analysis to
detect Snf1. Left lane, wild-type (UBP8) yeast strains expressing
6His-myc-ubiquitin; right lane, ubp8 strains expressing 6His-myc-
ubiquitin. IB, immunoblot. (B) A Snf1-FLAG immunoprecipitation
(IP) in wild-type and ubp8 strains containing or lacking a His-myc-Ub
reporter. (C) Northern blot (left) and quantitative RT-PCR (right; n
3) analyses of SNF1 mRNA levels in wild-type and ubp8 strains.
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ubp8 strains grown in activating (galactose) and nonactivating
(glucose) carbon sources. Since Snf1 steady-state levels are
decreased in ubp8 strains (Fig. 2A), we normalized the pro-
tein loads of Snf1 for these analyses. As expected, Snf1 T210
phosphorylation was regulated by the carbon source (Fig. 5B
[top panel, compare lanes 1 and 3] and C), as it was increased
in galactose-grown cells. In contrast, Snf1 T210 phosphoryla-
tion was reduced in ubp8 strains grown in galactose (Fig. 5B
[compare lanes 3 and 4] and C), suggesting that, as for other
AMP kinases, hyperubiquitination of Snf1 in the absence of
Ubp8 affects T210 phosphorylation and potentially Snf1 acti-
vation.
Snf1-mediated phosphorylation of Gal83 is decreased in
ubp8 strains. Decreased Snf1 T210 phosphorylation upon
increased ubiquitination could lead to a decrease in Snf1 ki-
nase activity. If so, then loss of Ubp8 might cause changes in
gene expression similar to those caused by loss of Snf1. There-
fore, we examined previously published microarray data and
found significant overlaps between changes in gene expression
reported for snf1 and ubp8 strains (16, 45). However, it is
difficult to distinguish which changes are direct or indirect, as
the SAGA complex and Snf1 each regulate many genes (Table
2). However, previously published chromatin immunoprecipi-
tation microarray analysis (ChIP-chip) data revealed signifi-
FIG. 2. The steady-state levels and stability of Snf1 are altered in ubp8 strains. (A) Western blot analysis of steady-state Snf1 levels in wild-type
(UBP8) and ubp8 strains. (B) Quantitation of Snf1 steady-state levels in UBP8 and ubp8 strains relative to the Pgk1 loading control was
performed by densitometry analyses (ImageQuant) (n 3). (C) Western blot analyses of Snf1 stability in wild-type cells (left), ubp8 cells (middle),
and ubp8 cells grown in the presence of the MG132 proteasome inhibitor (right). Strains were grown in galactose followed by a switch to growth
in glucose and cycloheximide (CHX; 100 g/ml) to shut off transcription and translation of the GAL-FLAG-SNF1 reporter. Snf1 levels were
analyzed at the indicated time points in each strain by anti-FLAG Western blot analysis. (D) A quantitative analyses of Snf1 stability in each strain
relative to Pgk1 was performed by densitometry analyses (ImageQuant) (n  3). (E) Western blot analyses of Snf1 stability of ubp8 cells and
wild-type (UBP8) cells grown in the presence of galactose (GAL) or glucose (GLU) relative to Pgk1. t1/2, half-life (in minutes).
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cant overlaps in Snf1 and Ubp8 binding at upstream activation
sites (UAS) and transcriptional start sites (TSS) of many genes
whose expression was affected by loss of these factors. This
overlap in function at these genes supports the idea that Ubp8
modulates the activity of Snf1 to fine-tune the regulation of
Snf1 target genes (Fig. 5A and Table 2) (16, 40, 45).
To more directly determine whether Snf1 activity is affected
by Ubp8 loss, we examined the phosphorylation status of a
Snf1 target protein. The Snf1 kinase complex is composed of a
catalytic alpha subunit (Snf1), one of three beta subunits
(Gal83, Sip1, and Sip2), and a gamma subunit (Snf4) (11).
Each of the three beta subunits interacts with Snf1 and Snf4 to
form three distinct isoforms of the Snf1 complex that have
overlapping functions. Strains containing null mutations in any
one of these proteins are viable on all carbon sources and show
no differences in the phosphorylation status of downstream
protein targets (32). Conversely, strains containing null muta-
tions in all three of the beta subunits of the Snf1 complex
phenocopy the growth and activity defects observed in snf1 null
mutants when grown on nonfermentable carbon sources (32).
While the beta subunits appear to have shared functions, they
can also confer substrate specificity to the Snf1 kinase complex,
and they have distinct roles in the cell during growth on specific
carbon sources (32).
The Snf1 complex containing the Gal83 beta subunit local-
izes to the nucleus during a switch from high- to low-glucose-
containing media. Therefore, it is likely that this isoform of the
Snf1 complex is posttranslationally modified by Ubp8. In ad-
dition, Gal83 is phosphorylated by Snf1 in vivo and in vitro (22,
41). Therefore, to determine if the hypophosphorylation of
Snf1 that we observe in ubp8 strains corresponds to a de-
crease in Snf1 activity, we monitored the phosphorylation sta-
tus of Gal83 in wild-type, ubp8, and snf1 strains grown in
activating (galactose) and nonactivating (glucose) carbon
sources. Like Snf1 T210 phosphorylation, the phosphorylation
of Gal83 is regulated by the carbon source (Fig. 5D, top panel,
compare lanes 1 and 4), as it is phosphorylated when cells are
grown in activating conditions. However, Gal83 phosphoryla-
tion is decreased in ubp8 strains (Fig. 5D, top panel, compare
lanes 1 and 2), suggesting that the decrease in Snf1 stability
and T210 phosphorylation that is observed in these strains
corresponds to a decrease in Snf1 activity.
DISCUSSION
One of the most studied modes of Snf1 regulation is the
phosphorylation of threonine 210, a mark which closely follows
Snf1 activation (14, 24, 36). In this study, we found that in
addition to being modified by phosphorylation, Snf1 is modi-
fied by ubiquitination. Moreover, we discovered that Snf1
ubiquitination is regulated by the SAGA complex, as Snf1
becomes hyperubiquitinated in the absence of Ubp8 (Fig. 1
and 6). Snf1 physically interacts with Ubp8 in vivo, and the
SAGA complex deubiquitinates Snf1 in vitro, in a Ubp8-de-
pendent manner. To our knowledge, Snf1 is the first nonhis-
tone substrate defined for the yeast DUB module of SAGA.
What is the biological function of Snf1 ubiquitination? One
method to determine whether hyperubiquitination of Snf1 in
ubp8 strains affects Snf1 activity is to determine whether
snf1 and ubp8 strains share growth defects. However, one
FIG. 3. Snf1 interacts with Ubp8 in vivo. (A and B) Whole-cell
extracts were collected from yeast strains expressing an empty vector
(lanes 1 and 5), Ubp8 with an N-terminal myc tag (lanes 2 and 6), or
Snf1 with a C-terminal FLAG tag (lanes 3 and 7) or coexpressing both
proteins (lanes 4 and 8). (A) Lysates were preincubated with 200 U of
DNase for 1 h followed by incubation with anti-FLAG antibody-con-
jugated agarose beads. Each sample was analyzed by SDS-PAGE fol-
lowed by anti-myc and anti-FLAG Western blot analyses. (B) Lysates
from each sample were also incubated with anti-myc antibody-conju-
gated agarose beads. Each sample was analyzed by SDS-PAGE fol-
lowed by anti-FLAG and anti-myc Western blot analyses. (C) Endog-
enously tagged Snf1 and Ubp8 interact in vivo. Whole-cell extracts
were collected from yeast strains expressing either a TAP-tagged ver-
sion of Ubp8 and Snf1, which has a natural stretch of histidine residues
(lane 1), or Snf1 with untagged Ubp8 (lane 2) or lacking Snf1 and
untagged Ubp8 (lane 3).
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problem with testing this hypothesis is that ubp8 strains, un-
like snf1 strains, have growth defects on preferred (control)
carbon sources (i.e., glucose [data not shown]), which makes
interpretation of any results difficult. However, our data indi-
cate that Ubp8 does in fact regulate Snf1, as it regulates both
the half-life of Snf1 and its kinase activity. Interestingly, while
ubiquitination of other AMP kinases (AMPKs) has been de-
scribed, only a few studies address the regulation of these
FIG. 4. SAGA deubiquitinates Snf1 in vitro. (A) Ubiquitinated histone H2B was purified in strains expressing a FLAG epitope-tagged H2B and
a 3HA epitope-tagged ubiquitin. Ubiquitination of purified H2B was confirmed by Western blotting with anti-H2B, anti-HA, and anti-FLAG
antibodies. (B) To confirm that SAGA directly deubiquitinates histone H2B in vitro, purified H2B was incubated in the absence (lane 1) and
presence of SAGA complexes that contained (lane 2) or lacked (lane 3) Ubp8. The ubiquitination status of H2B was monitored by Western blot
analyses with anti-H2B (top panel) and anti-HA (middle panel) antibodies. (C) Ubiquitinated Snf1 was purified from strains expressing a
FLAG-epitope tagged Snf1 and a 3HA epitope-tagged ubiquitin. Ubiquitination of the purified Snf1 was confirmed by Western blot analysis with
anti-FLAG and anti-HA antibodies. (D) Purified Snf1 was incubated in the absence (lane 1) or presence of SAGA complexes that contained (lane
2) or lacked (lane 3) the deubiquitination module. The ubiquitination status of Snf1 was monitored by Western blot analyses with anti-FLAG (top
panel) and anti-HA (middle panel) antibodies. (E) An in vitro histone acetyltransferase assay to determine the activity of SAGA complexes
containing (lane 3) and lacking (lane 4) Ubp8. 3H-AcCoA, [3H]acetyl-CoA. (F) An in vitro deubiquitination (DUB) assay to determine the DUB
activity of SAGA complexes containing (SAGA) and lacking (SAGA ubp8) Ubp8 toward the fluorogenic substrate, ubiquitin-AMC (Ub-amc),
as measured by fluorescence over time.
3132 WILSON ET AL. MOL. CELL. BIOL.
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
enzymes by ubiquitination. The mammalian USP9X deubiq-
uitinase regulates the ubiquitination status of the MARK4 and
NUAK1 AMPK-related kinases (1). Similar to what was seen
in our findings, MARK4 and NUAK1 are hyperubiquitinated
in the absence of USP9X. However, hyperubiquitination of
these enzymes does not seem to affect their stability but rather
has a negative effect on MARK4 and NUAK1 T-loop phos-
phorylation. Since ubiquitination of Snf1 not only affected its
stability, but like MARK4 and NUAK1, also had a negative
effect on its phosphorylation status, the activity of Snf1 is likely
tightly regulated by the opposing actions of Ubp8 and ubiquitin
ligases. In yeast and mammals, the major upstream activating
kinases of the SNF1 family of proteins (in yeast, Sak1, Tos3,
and Elm1, and in mammals, LKB1 and CaMKK) are consti-
tutively active (15). However, when cells are grown in activat-
ing conditions, only a fraction of these kinase targets is phos-
phorylated. Therefore, it is possible that in a system that is
“always on,” the ubiquitination/deubiquitination cycles of
SNF1 family members have evolved to allow only a portion of
each family member to be recognized by or accessible to these
upstream kinases. Similarly, Ubp8-mediated deubiquitination
of Snf1 may have evolved to fine-tune the spatial and temporal
activation of Snf1.
Snf1 can directly phosphorylate histone proteins, transcrip-
tional modulators, and the beta subunits of the Snf1 kinase
complex isoforms. Mutations that inactivate Snf1 cause a de-
FIG. 5. Hyperubiquitination of Snf1 fine-tunes its activity. (A) A graphical representation of Table 2, presenting Snf1 and Ubp8 ChIP-chip data
that were used in a comparative BLAST search in order to determine overlaps between Snf1 and Ubp8 binding sites (x axis) at the upstream
activation sites (UAS) and transcriptional start sites (TSS) of the indicated genes (y axis). Numbers represent numbers of genes. (B) Wild-type
(UBP8) and ubp8 cells expressing TAP-tagged Snf1 were lysed by alkaline lysis to monitor the phosphorylation status of Snf1 when cells were
grown in activating (galactose) or nonactivating (glucose) medium. To account for the decrease in steady-state levels of Snf1 in ubp8 strains that
we observed earlier, we loaded 3-fold more ubp8 lysates than wild-type lysates (lanes 2 and 4) into the lanes to normalize Snf1 between strains.
Snf1 T210 phosphorylation was monitored in each strain by Western blotting with anti-TAP and anti-phospho-Snf1 T210 antibodies. (C) Phospho-
Snf1 levels in UBP8 and ubp8 cells were measured relative to total Snf1 levels by using densitometry analyses (ImageQuant) (n  4). (D) Snf1
activity was monitored by measuring the phosphorylation status of Gal83. (Upper panel) Phospho-TAP-Gal83 staining; (lower panel) TAP-Gal83
Western blot. WT, wild type. (E) Phospho-Gal83 levels in WT, ubp8, and snf1 strains were measured relative to total Gal83 by using
densitometry analyses (ImageQuant) (n  4).
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crease in the phosphorylation of these downstream targets (22,
41). We show that SAGA, through the Ubp8 deubiquitinase,
fine-tunes these activities, as hyperubiquitination of Snf1 de-
creases phosphorylation of both Snf1 and its downstream tar-
get, Gal83. Therefore, Ubp8 functions positively reinforce
Snf1-mediated activities in the cell (Fig. 6).
Our data not only provide additional information about the
molecular mechanisms of the SAGA complex but also suggest
that ubiquitination of AMPKs provides a mechanism that is
conserved from yeast to humans for the regulation of their
activity. Future work will identify the ubiquitin ligase that is
responsible for Snf1 ubiquitination and the mechanism by
which Snf1 ubiquitination inhibits its activation.
Our current and previous works demonstrate that SAGA
utilizes multiple mechanisms to fine-tune gene expression
beyond chromatin structure. Therefore, like for the Snf1
AMPK, the identification and characterization of these ad-
ditional targets of the SAGA complex will be critical to
FIG. 6. Model of Ubp8-mediated regulation of Snf1. Model of how
Ubp8 and ubiquitination of Snf1 control Snf1 levels and kinase activity.
The SAGA complex (through the DUB module) deubiquitinates and
protects Snf1 from proteasome-mediated degradation. In addition,
Ubp8-mediated deubiquitination of Snf1 promotes Snf1 activation on
nonpreferred carbon sources and subsequent Snf1-mediated phos-
phorylation of specific downstream protein targets.
TABLE 2. ChIP-chip/microarray data intersections
Gene name
ChIP-chip binding of: Microarraya
Gene name
ChIP-chip binding: Microarray
Snf1-TAP Ubp8-TAP snf1 ubp8 Snf1-TAP Ubp8-TAP snf1 ubp8
UAS intersection YLR270W/DCS1 1.4 1.97 0.027567
YCR008W/SAT4 2.67 1.57 0.06098 YLR401C/DUS3 1.97 1.5 0.03535
YCR066W/RAD18 1.31 1.18 0.03486 YLR438W/CAR2 1.02 2.5 0.434 0.00273
YCR094W/CDC50 2.68 2.41 0.00221 YMR010W 1.74 2.08 0.28 0.014928
YDL021W/GPM2 1.55 1.1 0.0994 YMR012W/CLU1 1.15 1.01 0.168 0.05255
YDL045W_A/MRP10 1.44 1.05 0.07186 YMR234W/RNH1 2.59 2.48 0.074478
YDL058W/MRP10 1.65 1.87 0.04083 YMR262W 2.37 1.72 0.031968
YDR192C/NUP42 1.34 1.17 0.01565 YNL004W/HRB1 1.84 2.02 0.11802
YDR260C/SWM1 1.43 1.54 0.03153 YNL279W/PRM1 2.06 2.56
YDR316W-B 1.16 1.24 0.04028 YNR022C/MRPL50 1.22 1.34 0.12 0.01336
YDR358W/GGA1 3.13 2.66 0.12448 YOL020W/TAT2 1.12 1.66 0.388 0.026485
YDR514C 2.59 2.72 0.02023 YOR036W/PEP12 1.03 1.13 0.098957
YER039C-A 1.64 1.63 0.02868 YOR044W/IRC23 1.33 1.47 0.11018
YER057C/HIG1 1.11 1.54 0.083 0.0386 YOR100C/CRC1 1.97 2.86 0.749 0.065734
YER090W/TRP2 1.05 1.28 0.301 0.04919 YOR230W/WTM1 2.93 2.55 0.051374
YER091C/MET6 1.42 1.23 0.175 0.057372 YPL016W/SWI1 2.53 3.02 0.03849
YER103W/SSA4 1.03 1.39 0.09116 YPL033C/SRL4 2.56 2 0.537 0.01147
YER106W/MAM1 1.11 1.39 0.224 0.02062 YPL058C/PDR12 2.46 2.34 0.03959
YER146W/LSM5 1.12 1.67 0.01246 YPL104W/MSD1 1.37 1.17 0.113 0.05319
YER151C/UBP3 1.75 1.72 0.03038 YPL135W/ISU1 1.64 1.66 0.096 0.09092
YER182W/FMP10 1.14 1.48 0.316 0.00777 YPL180W/TOR89 1.62 2.41 0.00119
YGL138C 2.49 2.96 0.505 0.14168 YPL208W/RKM1 1.08 1.1 0.01421
YGL168W/HUR1 2.2 2.78 0.039632 YPL216W 1.38 1.76 0.011825
YGR154C/GTO1 2.25 1.62 0.03293 YPL220W/RPL1A 1.85 2.25 0.01482
YHL026C 2.48 3.17 0.000116 YPL231W/FAS2 3.18 3.08
YHR005C/GTA1 2.74 2.62 0.04459 YPR086W/SUA7 1.43 1.83 0.06619
YHR042W/NCP1 1.09 1.22 0.00386 YPR108W-A 2.53 1.91
YHR176W/FMO1 1.46 1.14 0.12725
YHR178W/STB5 1.07 1.37 0.009928 TSS intersection
YHR187W/IKI1 2.89 1.95 0.01426 YAR019C/CDC15 2.55 1.54 0.01449
YIL046W-A 2.29 2.1 YDL045W_A/MRP10 1.27 1.14 0.07186
YIL091C/UTP25 1.18 1.44 0.11593 YDL052C/SLC1 1.15 1.05 0.16
YJL073W/JEM1 1.29 1.25 0.173 0.08061 YDR358W/GGA1 1.34 1.34 0.12448
YKL061W/BLI1 3.14 3.07 0.018122 YKL095W/YJU2 1.25 1.34 0.074038
YKL112W/BAF1 2.35 2.26 0.05439 YKR045C 1.78 1.56 0.053793
YKL161C/KDX1 1.29 1.39 0.407 0.039902 YML094W/GIM5 1.98 2.68 0.027821
YKR024C/DPB7 1.1 1.06 0.193 0.02473 YNR057C/BIO4 1.57 2.02 0.185 0.11259
YKR090W/PXL1 1.87 2.47 0.12053 YPL245W 2.44 1.35 0.024861
YLR057W/MNL2 3.26 3.16 0.01818
YLR095C/IOC2 1.31 1.02 0.046575 UAS/TSS intersection
YLR154C-G 1.3 1.99 YDL045W_A/MRP10 1.27 1.14 0.0718
YLR187W/SKG3 2.28 1.35 0.332 0.10784 YDR358W/GGA1 1.34 1.34 0.1244
a Values are changes in gene expression.
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understanding the role that USP22 and SAGA play in the
death-from-cancer signature that is observed in various car-
cinomas (7, 8).
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